SCPH scPharmaceuticals Inc. Full Business Value

scpharmaceuticals.com - graphic logo of issuer SCPH

scPharmaceuticals Inc. (SCPH) offers wearable pumps for home heart therapy, where patient dependence on infusions creates steady demand for consumables. This chart of share prices on GURU.Markets, with a value of , depends on FDA decisions rather than economics. The business relies on a home treatment ecosystem that retains patients through cardiologist recommendations, minimizing hospitalizations.

SCPH (scPharmaceuticals, Inc.) Total Company Value history from 07/04/2022 to 10/28/2026
Original product of scPharmaceuticals

Enterprise Value (EV) combines market capitalization and net debt, reflecting the actual cost of a full business buyout accounting for liquidity. Analyzing the aggregate valuation level allows this value to be correlated with the sustainable cash flow from subcutaneous drug delivery systems, confirming the fundamental reliability of scPharmaceuticals Inc. (SCPH) amid stable clinical demand.

Competitor analysis for scPharmaceuticals Inc.

Haleon PLC - Real Price to Acquire Entire Company|Total Company Value Kenvue Corp|VRNA - Full Business Value|Enterprise Value Jyong Biotech Ltd MENS|LGND (ligand.com) - Value Adjusted for Debt and Cash|Total Company Value Amneal AMRX|Full Business Value Perrigo Company PLC|Alvotech Corp (ALVO) - Enterprise Value|Value Adjusted for Debt and Cash Liquidia Inc. (LQDA)|Enterprise Value GLPG (Galapagos NV)|anipharmaceuticals.com - Enterprise Value|Total Company Value MannKind (MNKD)|AMPH: Value Adjusted for Debt and Cash|PCRX (Pacira) - Total Company Value|ARS Corp (SPRY) - Real Price to Acquire Entire Company|TBPH (Theravance Biopharma) - Enterprise Value|Enterprise Value aquestive.com (AQST)|Tectonic Therapeutic, Inc. (TECX) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash TNXP (Tonix Pharma)|SXTC: Total Company Value|EPRX - Total Enterprise Value|Real Price to Acquire Entire Company BioHarvest Sciences BHST|EXOZ - Aggregate Business Value|Enterprise Value oramed.com ORMP|Entera Bio (ENTX) - Value Adjusted for Debt and Cash|Enterprise Value HYFT (MindWalk)|Total Enterprise Value ABVC|Cumberland Pharmaceuticals (CPIX) - Total Company Value|Value Adjusted for Debt and Cash QNTM (quantumbiopharma.com)|Total Company Value FGEN|Company Buyout Price Telomir Pharmaceuticals Inc TELO|RANI: Enterprise Value|SNYR: Real Price to Acquire Entire Company|Total Company Value rallybio.com (RLYB)|Lexaria Bioscience Corp. (LEXX) - Full Business Value|PULM - Enterprise Value|Value Adjusted for Debt and Cash Pheton|Enterprise Value APM|Enterprise Value LYRA (Lyra Therapeutics Inc)|Total Company Value Impact BioMedical|TNF Pharmaceuticals Inc. - Value Adjusted for Debt and Cash|YCBD: Total Company Value|PRFX - Real Price to Acquire Entire Company|CYTO: Enterprise Value|Lipella Pharma (LIPO) - Enterprise Value|Enterprise Value OPTN|Real Price to Acquire Entire Company pieris.com|Procaps - Enterprise Value|Total Enterprise Value Petros Pharmaceuticals Inc PTPI|Real Price to Acquire Entire Company QLI (Qilian International Holding Group Limited)|SLRN - Enterprise Value|Real Price to Acquire Entire Company TFF Pharmaceuticals TFFP